Cleared Traditional

K152996 - Molteno3 Glaucoma Implant

K152996 is the FDA 510(k) clearance for Molteno3 Glaucoma Implant by Innovative Ophthalmic Products, Inc. (Iop). It is a Class 2 Ophthalmic device (product code KYF) cleared through the Traditional 510(k) pathway after a 65-day FDA review.

K152996 · Innovative Ophthalmic Products, Inc. (Iop) · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
65d
Days
Class 2
Risk

K152996 is an FDA 510(k) clearance for the Molteno3 Glaucoma Implant. Classified as Implant, Eye Valve (product code KYF), Class II - Special Controls.

Submitted by Innovative Ophthalmic Products, Inc. (Iop) (Costa Mesa, US). The FDA issued a Cleared decision on December 17, 2015 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.3920 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Innovative Ophthalmic Products, Inc. (Iop) devices

Submission Details

510(k) Number K152996 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 13, 2015
Decision Date December 17, 2015
Days to Decision 65 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 110d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KYF Implant, Eye Valve
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.3920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.